| Lastest Insider Transactions Of LIGAND PHARMACEUTICALS INC ( LGND ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| LGND | LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | 2026-03-11 | Sell | 3,057 | 225.00 | 687,825 | 2026-03-13 19:29:34 |
| LGND | LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | 2026-03-11 | Option Exercise | 2,405 | 92.65 | 222,823 | 2026-03-13 19:29:34 |
| LGND | LIGAND PHARMACEUTICALS INC | Reardon Andrew | CLO & Secretary | 2026-03-04 | Sell | 5,000 | 206.35 | 1,031,770 | 2026-03-06 18:51:02 |
| LGND | LIGAND PHARMACEUTICALS INC | Reardon Andrew | CLO & Secretary | 2026-03-04 | Option Exercise | 5,000 | 52.27 | 261,350 | 2026-03-06 18:51:02 |
| LGND | LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | 2026-03-04 | Sell | 13,423 | 205.83 | 2,762,822 | 2026-03-06 18:49:54 |
| LGND | LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | 2026-03-04 | Option Exercise | 2,073 | 63.49 | 131,609 | 2026-03-06 18:49:54 |
| LGND | LIGAND PHARMACEUTICALS INC | Sabba Stephen L | Directior | 2026-03-03 | Sell | 2,034 | 201.50 | 409,851 | 2026-03-05 11:05:17 |
| LGND | LIGAND PHARMACEUTICALS INC | Sabba Stephen L | Directior | 2026-03-03 | Option Exercise | 2,034 | 69.51 | 141,383 | 2026-03-05 11:05:17 |
| LGND | LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Directior | 2026-03-02 | Sell | 467 | 200.50 | 93,632 | 2026-03-04 21:04:25 |
| LGND | LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Directior | 2026-02-02 | Sell | 467 | 195.91 | 91,490 | 2026-02-04 17:18:56 |
| LGND | LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Directior | 2026-01-02 | Sell | 467 | 189.58 | 88,532 | 2026-01-06 19:47:45 |
| LGND | LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | 2025-12-16 | Option Exercise | 2,381 | 69.00 | 164,298 | 2025-12-18 16:19:42 |
| LGND | LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | 2025-12-12 | Sell | 1,804 | 188.31 | 339,711 | 2025-12-16 18:36:31 |
| LGND | LIGAND PHARMACEUTICALS INC | Aryeh Jason | Directior | 2025-12-08 | Option Exercise | 2,034 | 69.51 | 141,383 | 2025-12-08 19:38:24 |
| LGND | LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Directior | 2025-12-01 | Sell | 467 | 195.84 | 91,457 | 2025-12-03 17:08:21 |
| LGND | LIGAND PHARMACEUTICALS INC | Gray Nancy Ryan | Directior | 2025-11-07 | Sell | 6,571 | 205.45 | 1,350,012 | 2025-11-12 16:45:03 |
| LGND | LIGAND PHARMACEUTICALS INC | Gray Nancy Ryan | Directior | 2025-11-07 | Option Exercise | 6,571 | 69.58 | 457,185 | 2025-11-12 16:45:03 |
| LGND | LIGAND PHARMACEUTICALS INC | LAMATTINA JOHN L | Directior | 2025-11-07 | Sell | 4,179 | 205.45 | 858,576 | 2025-11-12 16:44:42 |
| LGND | LIGAND PHARMACEUTICALS INC | LAMATTINA JOHN L | Directior | 2025-11-07 | Option Exercise | 4,179 | 67.78 | 283,232 | 2025-11-12 16:44:42 |
| LGND | LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Directior | 2025-11-03 | Sell | 467 | 191.05 | 89,219 | 2025-11-05 17:22:00 |
| LGND | LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Directior | 2025-10-01 | Sell | 467 | 179.44 | 83,800 | 2025-10-03 16:45:27 |
| LGND | LIGAND PHARMACEUTICALS INC | Aryeh Jason | Directior | 2025-09-23 | Sell | 10,000 | 170.81 | 1,708,088 | 2025-09-24 17:11:02 |
| LGND | LIGAND PHARMACEUTICALS INC | Aryeh Jason | Directior | 2025-09-23 | Sell | 10,000 | 170.81 | 1,708,088 | 2025-09-24 17:11:02 |
| LGND | LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Directior | 2025-09-02 | Sell | 467 | 162.26 | 75,775 | 2025-09-04 17:47:34 |
| LGND | LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Directior | 2025-08-01 | Sell | 467 | 131.88 | 61,586 | 2025-08-05 17:03:25 |
| LGND | LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Directior | 2025-07-10 | Sell | 934 | 125.00 | 116,750 | 2025-07-11 18:17:22 |
| LGND | LIGAND PHARMACEUTICALS INC | Reardon Andrew | CLO & Secretary | 2025-06-23 | Sell | 500 | 114.08 | 57,042 | 2025-06-24 20:29:59 |
| LGND | LIGAND PHARMACEUTICALS INC | Reardon Andrew | CLO & Secretary | 2025-06-10 | Sell | 500 | 114.54 | 57,271 | 2025-06-12 17:51:36 |
| LGND | LIGAND PHARMACEUTICALS INC | Reardon Andrew | CLO & Secretary | 2024-08-10 | Sell | 1,000 | 104.00 | 104,000 | 2025-06-02 20:06:06 |
| LGND | LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Directior | 2025-01-17 | Option Exercise | 2,406 | 52.30 | 125,834 | 2025-06-02 20:05:50 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | 2025-05-09 | Buy | 9,510 | 105.20 | 1,000,456 | 2025-05-13 20:05:16 |
| LGND | LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | 2025-05-09 | Buy | 1,500 | 104.06 | 156,090 | 2025-05-13 20:04:05 |
| LGND | LIGAND PHARMACEUTICALS INC | Sabba Stephen L | Directior | 2025-04-01 | Option Exercise | 2,406 | 52.30 | 125,834 | 2025-04-16 09:34:19 |
| LGND | LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | 2025-03-04 | Sell | 5,000 | 115.03 | 575,149 | 2025-03-06 18:55:23 |
| LGND | LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | 2024-12-23 | Sell | 2,104 | 116.37 | 244,850 | 2024-12-26 20:32:43 |
| LGND | LIGAND PHARMACEUTICALS INC | LAMATTINA JOHN L | Directior | 2024-11-27 | Sell | 2,406 | 123.65 | 297,502 | 2024-12-02 20:05:58 |
| LGND | LIGAND PHARMACEUTICALS INC | LAMATTINA JOHN L | Directior | 2024-11-27 | Option Exercise | 2,406 | 52.30 | 125,834 | 2024-12-02 20:05:58 |
| LGND | LIGAND PHARMACEUTICALS INC | Reardon Andrew | CLO & Secretary | 2024-09-23 | Sell | 2,000 | 99.60 | 199,201 | 2024-09-25 20:54:39 |
| LGND | LIGAND PHARMACEUTICALS INC | Reardon Andrew | CLO & Secretary | 2024-09-23 | Option Exercise | 2,000 | 52.27 | 104,540 | 2024-09-25 20:54:39 |
| LGND | LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | 2024-09-20 | Sell | 1,275 | 103.94 | 132,518 | 2024-09-24 19:41:37 |
| LGND | LIGAND PHARMACEUTICALS INC | Korenberg Matthew E | President & COO | 2024-09-20 | Sell | 16,047 | 102.35 | 1,642,359 | 2024-09-24 19:41:15 |
| LGND | LIGAND PHARMACEUTICALS INC | Korenberg Matthew E | President & COO | 2024-09-20 | Option Exercise | 14,754 | 51.80 | 764,277 | 2024-09-24 19:41:15 |
| LGND | LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | 2024-09-17 | Option Exercise | 1,486 | 79.63 | 118,328 | 2024-09-19 17:50:09 |
| LGND | LIGAND PHARMACEUTICALS INC | Korenberg Matthew E | President & COO | 2024-09-16 | Option Exercise | 5,774 | 58.49 | 337,696 | 2024-09-18 19:55:29 |
| LGND | LIGAND PHARMACEUTICALS INC | Korenberg Matthew E | President & COO | 2024-08-09 | Sell | 18,245 | 98.50 | 1,797,133 | 2024-08-13 17:21:14 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | 2024-08-08 | Buy | 2,500 | 97.39 | 243,481 | 2024-08-09 17:52:17 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | 2024-08-08 | Buy | 2,500 | 97.39 | 243,481 | 2024-08-09 17:52:17 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | 2024-08-08 | Buy | 2,500 | 97.39 | 243,481 | 2024-08-09 17:52:17 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | 2024-08-08 | Buy | 2,500 | 97.39 | 243,481 | 2024-08-09 17:52:17 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | 2024-08-08 | Buy | 2,500 | 97.39 | 243,481 | 2024-08-09 17:52:17 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | 2024-08-08 | Buy | 2,500 | 97.39 | 243,481 | 2024-08-09 17:52:17 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | 2024-08-08 | Buy | 2,500 | 97.39 | 243,481 | 2024-08-09 17:52:17 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | 2024-08-08 | Buy | 2,500 | 97.39 | 243,481 | 2024-08-09 17:49:46 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | 2024-08-08 | Buy | 2,500 | 97.39 | 243,481 | 2024-08-09 17:49:46 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | 2024-08-08 | Buy | 2,500 | 97.39 | 243,481 | 2024-08-09 17:49:46 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | 2024-08-08 | Buy | 2,500 | 97.39 | 243,481 | 2024-08-09 17:49:46 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | 2024-08-08 | Buy | 2,500 | 97.39 | 243,481 | 2024-08-09 17:49:46 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | 2024-08-08 | Buy | 2,500 | 97.39 | 243,481 | 2024-08-09 17:49:46 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | 2024-08-08 | Buy | 2,500 | 97.39 | 243,481 | 2024-08-09 17:49:46 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | 2024-08-08 | Buy | 2,500 | 97.39 | 243,481 | 2024-08-09 17:49:46 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | 2024-08-08 | Buy | 2,500 | 97.39 | 243,481 | 2024-08-09 17:49:46 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | 2024-08-08 | Buy | 2,500 | 97.39 | 243,481 | 2024-08-09 17:49:46 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | 2024-08-08 | Buy | 2,500 | 97.39 | 243,481 | 2024-08-09 17:49:46 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | 2024-08-08 | Buy | 2,500 | 97.39 | 243,481 | 2024-08-09 17:49:46 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | 2024-08-08 | Buy | 2,500 | 97.39 | 243,481 | 2024-08-09 17:49:46 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | 2024-08-08 | Buy | 2,500 | 97.39 | 243,481 | 2024-08-09 17:49:46 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | 2024-08-08 | Buy | 2,500 | 97.39 | 243,481 | 2024-08-09 17:49:46 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | 2024-08-08 | Buy | 2,500 | 97.39 | 243,481 | 2024-08-09 17:49:46 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | 2024-08-08 | Buy | 2,500 | 97.39 | 243,481 | 2024-08-09 17:49:46 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | 2024-08-08 | Buy | 2,500 | 97.39 | 243,481 | 2024-08-09 17:49:46 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | 2024-08-08 | Buy | 2,500 | 97.39 | 243,481 | 2024-08-09 17:49:46 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | 2024-08-08 | Buy | 2,500 | 97.39 | 243,481 | 2024-08-09 17:49:46 |
| LGND | LIGAND PHARMACEUTICALS INC | Gray Nancy Ryan | Directior | 2024-05-09 | Sell | 934 | 83.20 | 77,713 | 2024-05-17 20:00:48 |
| LGND | LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | 2024-05-15 | Sell | 13,293 | 86.26 | 1,146,704 | 2024-05-17 19:59:50 |
| LGND | LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | 2024-05-15 | Option Exercise | 6,917 | 55.71 | 385,346 | 2024-05-17 19:59:50 |
| LGND | LIGAND PHARMACEUTICALS INC | Korenberg Matthew E | President & Chief Operating | 2024-05-13 | Sell | 17,598 | 84.99 | 1,495,741 | 2024-05-15 19:34:53 |
| LGND | LIGAND PHARMACEUTICALS INC | Reardon Andrew | Chief Legal Officer & | 2024-05-09 | Sell | 10,000 | 83.04 | 830,449 | 2024-05-13 17:32:46 |
| LGND | LIGAND PHARMACEUTICALS INC | Reardon Andrew | Chief Legal Officer & | 2024-05-09 | Option Exercise | 10,000 | 52.27 | 522,700 | 2024-05-13 17:32:46 |
| LGND | LIGAND PHARMACEUTICALS INC | Aryeh Jason | Directior | 2024-04-30 | Option Exercise | 2,406 | 52.30 | 125,834 | 2024-05-02 18:07:17 |
| LGND | LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Directior | 2024-04-24 | Option Exercise | 2,893 | 39.35 | 113,840 | 2024-04-26 18:35:31 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | 2024-03-25 | Option Exercise | 16,015 | 57.39 | 919,147 | 2024-03-27 17:47:59 |
| LGND | LIGAND PHARMACEUTICALS INC | Sabba Stephen L | Directior | 2024-03-05 | Sell | 1,893 | 74.30 | 140,650 | 2024-03-07 13:27:20 |
| LGND | LIGAND PHARMACEUTICALS INC | Sabba Stephen L | Directior | 2024-03-05 | Option Exercise | 2,893 | 0.00 | 0 | 2024-03-07 13:27:20 |
| LGND | LIGAND PHARMACEUTICALS INC | Aryeh Jason | Directior | 2024-03-05 | Option Exercise | 2,893 | 39.35 | 113,840 | 2024-03-06 17:28:44 |
| LGND | LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | 2024-02-27 | Sell | 140 | 88.46 | 12,384 | 2024-02-29 18:50:28 |
| LGND | LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | 2024-02-27 | Option Exercise | 1,264 | 56.62 | 71,564 | 2024-02-29 18:50:28 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | CHIEF EXECUTIVE OFFICER | 2023-09-22 | Buy | 4,000 | 59.38 | 237,529 | 2023-09-25 16:44:43 |
| LGND | LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Directior | 2023-05-16 | Sell | 4,444 | 77.20 | 343,081 | 2023-05-18 17:18:57 |
| LGND | LIGAND PHARMACEUTICALS INC | Sabba Stephen L | Directior | 2023-05-10 | Sell | 6,408 | 77.13 | 494,225 | 2023-05-12 15:43:24 |
| LGND | LIGAND PHARMACEUTICALS INC | Sabba Stephen L | Directior | 2023-05-10 | Option Exercise | 6,408 | 0.00 | 0 | 2023-05-12 15:43:24 |
| LGND | LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Directior | 2023-05-08 | Sell | 6,408 | 76.56 | 490,628 | 2023-05-10 19:15:17 |
| LGND | LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Directior | 2023-05-08 | Option Exercise | 6,408 | 18.82 | 120,599 | 2023-05-10 19:15:17 |
| LGND | LIGAND PHARMACEUTICALS INC | Reardon Andrew | See Remarks | 2023-03-24 | Sell | 300 | 69.92 | 20,977 | 2023-03-28 17:00:13 |
| LGND | LIGAND PHARMACEUTICALS INC | HIGGINS JOHN L | Directior | 2022-12-16 | Sell | 10,000 | 61.87 | 618,657 | 2022-12-20 18:36:56 |
| LGND | LIGAND PHARMACEUTICALS INC | HIGGINS JOHN L | Directior | 2022-12-12 | Option Exercise | 20,000 | 12.78 | 255,600 | 2022-12-14 17:00:25 |
